Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Contralesional Inhibitory rTMS for Recovery of Arm Function After Stroke

NCT: NCT04205526 · COMPLETED

NCT IDNCT04205526
StatusCOMPLETED
Start Date2021-03-01
Completion2025-12-31
SponsorThiel, Alexander, M.D. (INDIV)
First posted
Last updated

Brief Summary

The CanStim consensus working group (multidisciplinary team of experts in rTMS from institutions across Canada) developed consensus recommendations for a protocol to deliver rTMS as an adjunct to a standard behavioral intervention to improve functional outcomes after stroke in a national stroke rehabilitation clinical trial. The overall goal of this multi-center feasibility trial is not to demonstrate that rTMS is effective, but to demonstrate that each site can recruit the assigned number of patients within a certain period, perform the stimulation procedure in conjunction with the protocol-specified intervention, complete the therapy protocol and enter complete datasets for each patient into the CanStim database. A secondary aim is to identify potential weaknesses of the consensus protocol that may need to be modified before performing a larger scale trial testing for the efficacy of the intervention. A tertiary goal is to examine sex differences in neurophysiological recovery (motor evoked potential and arm functional movement recovery) after 15 treatment sessions of repetitive transcranial magnetic stimulation (rTMS) and to identify sex and gender-related factors that predict the post-stroke recovery.

Frequently Asked Questions

What is Contralesional Inhibitory rTMS for Recovery of Arm Function After Stroke?

Contralesional Inhibitory rTMS for Recovery of Arm Function After Stroke is a clinical trial registered under NCT04205526. Current status: COMPLETED.

What is the status of NCT04205526?

The current status of NCT04205526 (Contralesional Inhibitory rTMS for Recovery of Arm Function After Stroke) is: COMPLETED.

When did Contralesional Inhibitory rTMS for Recovery of Arm Function After Stroke start?

Contralesional Inhibitory rTMS for Recovery of Arm Function After Stroke started on 2021-03-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.